Tazarotene Cream
Product Images NDC 45802-706

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 45802-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton Rev05 24)

Packaging label for Tazarotene Cream 0.05%, a 30 g tube of topical cream by Padagis Israel Pharmaceuticals Ltd. The label includes active and inactive ingredients, storage instructions, and usage cautions. The design features the product name with concentration highlighted, the Padagis logo, barcodes, and regulatory information for prescription use only.*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure of tazarotene, showing its molecular framework including a thiophene ring, a pyridine ring, and an ester functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.